JPRN-jRCT2080223686未知1 期
Phase 1 Clinical Study of JTS-661 - Pharmacokinetic Study in Patients on Hemodialysis
JAPAN TABACCO INC.0 个研究点目标入组 6 人开始时间: 2017年10月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Japanese patients aged 20 to 80 years (inclusive) at consent; however, female subjects must be postmenopausal
- •- Patients on hemodialysis (including hemodiafiltration) three times a week for at least 12 weeks before the screening visit
- •- Outpatients
排除标准
- 未提供
研究者
相似试验
未知
2 期
Early Phase 2 Clinical Study of JTS-661 - Efficacy and Safety StudyPruritusJPRN-jRCT2080223725JAPAN TABACCO INC.240
未知
2 期
The early Phase 2 clinical study of JTS-653 in Post-Herpetic NeuralgiaPost-Herpetic NeuralgiaJPRN-jRCT2080221142JAPAN TABACCO INC.160
已完成
1 期
Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 DiabetesDiabetes Mellitus, Type 2NCT04465877Akros Pharma Inc.37
已完成
不适用
A phase I clinical pharmacology study of SJP-0139 with a single-dose and multiple-dose administration in healthy male volunteersJapanese healthy adult male volunteersJPRN-UMIN000030621Senju Pharmaceutical Co.,Ltd.12
已完成
不适用
A phase I clinical pharmacology study of SJP-0135Healthy adultsJPRN-UMIN000029001Senju Pharmaceutical Co.,Ltd.30